Active targeting of mesoporous silica drug carriers enhances γ-secretase inhibitor efficacy in an in vivo model for breast cancer

R. Wittig, J.M. Rosenholm, E. Haartman, Von, J. Hemming, F. Genze, L. Bergman, T. Simmet, M. Lindén, C. Sahlgren

Research output: Contribution to journalArticleAcademicpeer-review

28 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Active targeting of mesoporous silica drug carriers enhances γ-secretase inhibitor efficacy in an in vivo model for breast cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science